Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07063992 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Thoracic Spine Manipulation With and Without Costovertebral Joint Manipulation in Patients Mid-back Pain

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Completed without a posted recruiting period Show 8 more changesShow less
    • Final enrollment: 47 participants (planned 34)
    • Interventions modified
    • Primary completion date changed from estimate of Oct 2025 to Oct 20, 2025
    • Study completion date changed from estimate of Oct 2025 to Oct 30, 2025
    • Start date changed from estimate of Jul 2025 to Jul 25, 2025
    • Eligibility criteria expanded, about 7 words
    • Site contact updated
    • Publications: details revised at 6 of 7 entries
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mid-back pain (mbp) is defined as pain occurring within the limits of the third thoracic (T3) and ninth thoracic (T9) vertebrae, caused by the dysfunction of the musculoskeletal structures in the thoracic spine. It can present as pain and/or burning between the shoulder blades with reduced thoracic spine mobility and increased muscle tension. Congenital disorders such as scoliosis and Scheuermann's disease, or acquired disorders such as thoracic facet and costovertebral joint dysfunction may cause mid back pain.
Trial Details
NCT Number NCT07063992
Lead Sponsor Riphah International University
Conditions
(from sponsor)
Back Pain
Related terms Back Pain
Enrollment 47 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov